Present concepts in management of atrial fibrillation: From drug therapy to ablation.

Atrial fibrillation (AF) management requires knowledge of its pattern of presentation, underlying conditions, and decisions about restoration and maintenance of sinus rhythm, control of the ventricular rate, and anti-thrombotic therapy. Maintenance of sinus rhythm is a desirable goal in AF patients because the prevention of recurrence may improve cardiac function, relieve symptoms and reduce the likelihood of adverse events. Anti-arrhythmic drug therapy is the first-line treatment for patients with paroxysmal and persistent AF based on current guidelines. However, currently used drugs have limited efficacy and cause cardiac and extracardiac toxicity. Thus, there is a continued need to develop new drugs, device and ablative approaches to rhythm management. Additionally, simpler and safer stroke prevention regimens are needed for AF patients on life-long anticoagulation, including occlusion of the left atrial appendage. The results of the Randomized Evaluation of Long-Term Anticoagulant Therapy study are encouraging in these settings. Knowledge on the pathophysiology of AF is rapidly expanding and identification of focally localized triggers has led to the development of new treatment options for this arrhythmia. Conversely, the clinical decision whether to restore and maintain sinus rhythm or simply control the ventricular rate has remained a matter of intense debate. In the minority of patients in whom AF cannot be adequately managed by pharmacological therapy, the most appropriate type of non-pharmacological therapy must be selected on an individualized basis. Curative treatment of AF with catheter ablation is now a legitimate option for a large number of patients. The evolution of hybrid therapy, in which two or more different strategies are employed in the same patient, may be an effective approach to management of AF. In any case, planning a treatment regimen for AF should include evaluation of the risks inherent in the use of various drugs as well as more invasive strategies.

[1]  S. Connolly,et al.  Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.

[2]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[3]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[4]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[5]  Frank Bogun,et al.  A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. , 2009, Journal of the American College of Cardiology.

[6]  J. Healey,et al.  A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.

[7]  C. Tondo,et al.  Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy , 2009, Journal of cardiovascular electrophysiology.

[8]  F. Sacher,et al.  Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.

[9]  Atul Verma,et al.  Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. , 2008, Heart rhythm.

[10]  Jeremy N Ruskin,et al.  Initial experience with the Mesh catheter for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. , 2008, Heart rhythm.

[11]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[12]  Michael A. E. Schneider,et al.  Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. , 2008, Journal of the American College of Cardiology.

[13]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[14]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[15]  F. Romeo,et al.  Transthoracic Versus Transesophageal Cardioversion of Atrial Fibrillation under Light Sedation: A Prospective Randomized Trial , 2007, Pacing and clinical electrophysiology : PACE.

[16]  R. Mantovan,et al.  Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. , 2007, Heart rhythm.

[17]  E. Aliot,et al.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.

[18]  S. Yusuf,et al.  Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study. , 2007, American heart journal.

[19]  M. Santini,et al.  Outpatient oesophageal–precordial electrical cardioversion of atrial fibrillation: an effective and safe technique to restore sinus rhythm , 2007, Journal of cardiovascular medicine.

[20]  C. Armon Amiodarone for atrial fibrillation. , 2007, The New England journal of medicine.

[21]  Frank Bogun,et al.  Radiofrequency Catheter Ablation of Chronic Atrial Fibrillation Guided by Complex Electrograms , 2007, Circulation.

[22]  G. Hindricks,et al.  Venice Chart International Consensus Document on Atrial Fibrillation Ablation , 2007, Journal of cardiovascular electrophysiology.

[23]  J. Ruskin,et al.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.

[24]  David O. Martin,et al.  Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. , 2007, Journal of the American College of Cardiology.

[25]  A. Goette,et al.  Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling). , 2007, Current opinion in pharmacology.

[26]  Tom Wong,et al.  Initial Experience Using a Forward Directed, High‐Intensity Focused Ultrasound Balloon Catheter for Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[27]  V. Santinelli,et al.  A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.

[28]  C. Tondo,et al.  Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular Function , 2006, Pacing and clinical electrophysiology : PACE.

[29]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[30]  Susan B. Johnson,et al.  Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. , 2005, Journal of the American College of Cardiology.

[31]  G. Lip,et al.  Antithrombotic treatment in atrial fibrillation , 2005, Postgraduate Medical Journal.

[32]  P. Teirstein,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.

[33]  M. Santini,et al.  Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique , 2005, Expert review of cardiovascular therapy.

[34]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[35]  D. Reda,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[36]  Elia Biganzoli,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[37]  Douglas Packer,et al.  Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.

[38]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[39]  K. Nademanee,et al.  A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.

[40]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[41]  M. Santini,et al.  Oesophageal electrical cardioversion of atrial fibrillation. , 2004, Minerva Cardioangiologica : a Journal on Cardiovascular Pathophysiology, Clinical Medicine and Therapy.

[42]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[43]  David O. Martin,et al.  Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. , 2004, Journal of the American College of Cardiology.

[44]  P. McCarthy,et al.  Advances in surgical treatment of atrial fibrillation. , 2004, Stroke.

[45]  L. Tamariz,et al.  Pharmacological rate control of atrial fibrillation. , 2004, Cardiology clinics.

[46]  Otto Kamp,et al.  Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. , 2004, Journal of the American College of Cardiology.

[47]  J. Boineau,et al.  The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. , 2003, The Journal of thoracic and cardiovascular surgery.

[48]  Affirm Investigators Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. , 2003, Journal of the American College of Cardiology.

[49]  Hirotsugu Yamada,et al.  Phased-Array Intracardiac Echocardiography Monitoring During Pulmonary Vein Isolation in Patients With Atrial Fibrillation: Impact on Outcome and Complications , 2003, Circulation.

[50]  M. Bulsara,et al.  The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.

[51]  U. Tebbe,et al.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.

[52]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[53]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[54]  R. Kerber,et al.  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. , 2002, Journal of the American College of Cardiology.

[55]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[56]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[57]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[58]  C. Kang,et al.  Modifications of the Cox-Maze III procedure. , 2000, The Annals of thoracic surgery.

[59]  P. Tchou,et al.  First Human Experience With Pulmonary Vein Isolation Using a Through-the-Balloon Circumferential Ultrasound Ablation System for Recurrent Atrial Fibrillation , 2000, Circulation.

[60]  A. Aggarwal Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[61]  S. Connolly,et al.  Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .

[62]  P. Tchou,et al.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[63]  O. Benavente,et al.  Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.

[64]  C. Pandozi,et al.  Single Shock Endocavitary Low Energy Intracardiac Cardioversion of Chronic Atrial Fibrillation , 1999, Journal of Interventional Cardiac Electrophysiology.

[65]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[66]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[67]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[68]  J. Boineau,et al.  Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. , 1995, The Journal of thoracic and cardiovascular surgery.

[69]  W. Stevenson,et al.  Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. , 1995, The American journal of cardiology.

[70]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[71]  Y. Kawashima,et al.  Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease. , 1994, The Journal of thoracic and cardiovascular surgery.

[72]  P B Corr,et al.  The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.

[73]  W. Kannel,et al.  Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.

[74]  B. Gersh,et al.  Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[75]  E. Benjamin,et al.  Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.

[76]  J. Camm,et al.  Statins and polyunsaturated fatty acids for treatment of atrial fibrillation , 2008, Nature Clinical Practice Cardiovascular Medicine.

[77]  Antonio De Simone,et al.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.

[78]  J. Halperin,et al.  Obliteration of the left atrial appendage for prevention of thromboembolism. , 2003, Journal of the American College of Cardiology.

[79]  S Nattel,et al.  Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. , 2000, The New England journal of medicine.